SCHEMBL30316949

SCHEMBL30316949

Fc1n[nH]c2nc(Cl)cnc12

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 2/20 0.31
▸ SGK1 O00141 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25204873 1.00 GRM4 (0.31) GRM4SGK1
SCHEMBL25208146 0.80 GRM4 (0.33) GRM4
SCHEMBL30849114 0.80 GRM4 (0.33) GRM4
SCHEMBL24283777 0.77 GRM4 (0.31) GRM4
SCHEMBL29490926 0.77 GRM4 (0.31) GRM4
SCHEMBL30424529 0.77 GRM4 (0.31) GRM4
SCHEMBL23169547 0.77 ALDH1A1 (0.37) GRM4SGK1
SCHEMBL30328027 0.77 GRM4 (0.31) GRM4
SCHEMBL23064021 0.72 HCAR2 (0.40) —
SCHEMBL23443035 0.69 MAPK1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4363423-A1 CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2024-05-08 — — EP disclosed
WO-2023278326-A1 CDK2 INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2023-01-05 — — WO disclosed
Send feedback